Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk

Debabrata Mukherjee; Derek P. Chew; Mark Robbins; Jay S. Yadav; Russell E. Raymond; David J. Moliterno

doi:10.1023/A:1011228817265

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk

Debabrata Mukherjee, Derek P. Chew, Mark Robbins, Jay S. Yadav, Russell E. Raymond, David J. Moliterno

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA™, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.

Original language	English
Pages (from-to)	151-154
Number of pages	4
Journal	Journal of Thrombosis and Thrombolysis
Volume	11
Issue number	2
DOIs	https://doi.org/10.1023/A:1011228817265
Publication status	Published or Issued - 2001
Externally published	Yes

Keywords

Abciximab
Coronary artery disease
GP IIb/IIIa inhibitor
Percutaneous intervention
Platelet

ASJC Scopus subject areas

Hematology
Cardiology and Cardiovascular Medicine

Access to Document

10.1023/A:1011228817265

Cite this

@article{fa70fb4960f644a6b782aee9512cdec9,

title = "Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk",

abstract = "The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA{\texttrademark}, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.",

keywords = "Abciximab, Coronary artery disease, GP IIb/IIIa inhibitor, Percutaneous intervention, Platelet",

author = "Debabrata Mukherjee and Chew, \{Derek P.\} and Mark Robbins and Yadav, \{Jay S.\} and Raymond, \{Russell E.\} and Moliterno, \{David J.\}",

year = "2001",

doi = "10.1023/A:1011228817265",

language = "English",

volume = "11",

pages = "151--154",

journal = "Journal of Thrombosis and Thrombolysis",

issn = "0929-5305",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk

AU - Mukherjee, Debabrata

AU - Chew, Derek P.

AU - Robbins, Mark

AU - Yadav, Jay S.

AU - Raymond, Russell E.

AU - Moliterno, David J.

PY - 2001

Y1 - 2001

N2 - The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA™, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.

AB - The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA™, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.

KW - Abciximab

KW - Coronary artery disease

KW - GP IIb/IIIa inhibitor

KW - Percutaneous intervention

KW - Platelet

UR - https://www.scopus.com/pages/publications/0034917539

U2 - 10.1023/A:1011228817265

DO - 10.1023/A:1011228817265

M3 - Article

C2 - 11406730

AN - SCOPUS:0034917539

SN - 0929-5305

VL - 11

SP - 151

EP - 154

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

IS - 2

ER -

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this